Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- 1 in 5 Japanese May Suffer from Diabetes: Korosho Survey
September 1, 2003
- BI to Further Collaborate with Japanese Firms: Prof. Krebs
September 1, 2003
- REGULATORY NEWS IN BRIEF
September 1, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 1, 2003
- ON THE MOVE
September 1, 2003
- Dainippon to Promote Better Cancer Pain Management
September 1, 2003
- Don Quijote to Provide Free OTC Drugs in Late Night Emergencies
September 1, 2003
- Merck & Co. Determined to Acquire All Shares of Banyu
September 1, 2003
- Anti-fatigue Food, Drug Development Project to Start from October: Soiken
September 1, 2003
- WORLD NEWS IN BRIEF
August 25, 2003
- BULLETIN
August 25, 2003
- Effects of Triptan-type Migraine Drugs Differ by Patient
August 25, 2003
- BUSINESS NEWS IN BRIEF
August 25, 2003
- JPMA's R&D Committee to Focus on Pharmacogenomics: New Chairman
August 25, 2003
- Yonyaku to Bolster Alliance with Nakazawa Ujike
August 25, 2003
- NEW PRODUCTS
August 25, 2003
- API to Expand Contract Mfg of Investigational, Bulk Drugs
August 25, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 25, 2003
- Livalo to Drive Kowa's Growth
August 25, 2003
- Annual Financial Results
August 25, 2003
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…